Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom

di Roos, Jonathan C. P., Murthy, Rachna
Pubblicato in Eye (Lond) (2018)

Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves’ orbitopathy

di Roos, Jonathan C. P., Murthy, Rachna
Pubblicato in Eye (Lond) (2019)

Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy

di Roos, Jonathan C. P., Paulpandian, Vignesh, Murthy, Rachna
Pubblicato in Eye (Lond) (2018)

Clinical pathophysiology of thyroid eye disease: The Cone Model

di Meyer, Paul, Das, Tilak, Ghadiri, Nima, Murthy, Rachna, Theodoropoulou, Sofia
Pubblicato in Eye (Lond) (2019)

Improving aseptic injection standards in aesthetic clinical practice

di Murthy, Rachna, Eccleston, David, Mckeown, Darren, Parikh, Apul, Shotter, Sophie
Pubblicato in Dermatol Ther (2020)

T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study

di Das, Tilak, Roos, Jonathan C. P., Patterson, Andrew J., Graves, Martin J., Murthy, Rachna
Pubblicato in Eye (Lond) (2018)

Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves’ orbitopathy: a case series

di Roos, Jonathan C. P., Moran, Carla, Chatterjee, V. Krishna, Jones, Joanne, Coles, Alasdair, Murthy, Rachna
Pubblicato in Eye (Lond) (2018)

Suture midface suspension

di Ugurbas, Suat H, Goldberg, Robert A, McCann, John D, Shorr, Norman, Murthy, Rachna, Ben Simon, Guy J
Pubblicazione 2006